Inhibition of tumor growth by the antiangiogenic placental hormone, proliferin-related protein

Molecular Endocrinology

Volumn 14, Issue 12, 2000, Pages 1934-1943

  Bengtson, N W ^a   Linzer, D I H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; PLACENTA PROTEIN; PLACENTAL PEPTIDE HORMONE; PROLIFERIN RELATED PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL STRAIN 3T3; CONTROLLED STUDY; FEMALE; FIBROBLAST; GLIOMA CELL; GROWTH RATE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALIA; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0034534324     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.12.0573     Document Type: Article

References (27)

1. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein
2. GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo
3. The placenta and the prolactin family of hormones: Regulation of the physiology of pregnancy
4. Trophoblastic giant cells of the mouse placenta as the site of proliferin synthesis
5. Characterization of proliferin-related protein
6. Proliferin transport and binding in the mouse fetus
7. Pituitary-placental interaction during pregnancy: Regulation of prolactin-like proteins
8. What is the evidence that tumors are angiogenesis dependent?
9. The role of angiogenesis in tumor growth
10. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
11. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
12. Tumor angiogenesis
13. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone
14. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease
15. The butler did it: Search for killer(s) of Kaposi's sarcoma cells in preparations of human chorionic gonadotropin
16. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo
17. Development of 3T3-like lines from Balb-c mouse embryo cultures: Transformation susceptibility to SV40
18. Differentiated rat glial cell strain in tissue culture
19. Neovascularization induced growth of implanted C6 glioma multicellular spheroids: Magnetic resonance microimaging
20. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
21. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
22. Placental prolactins and the physiology of pregnancy
23. Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive pathway regulating phospholipase A2 activity
24. Proliferin induces endothelial cell chemotaxis through a G protein-coupled, MAP kinase-dependent pathway
25. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
26. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
27. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice